Patient-based evaluations of primary care for cardiovascular diseases: a comparison between conventional and complementary medicine

Journal of Evaluation in Clinical Practice
Klazien Matter-WalstraAndré Busato

Abstract

Patients with chronic diseases, including cardiovascular conditions, increasingly rely on complementary and alternative medical (CAM) therapies. The Swiss Program for Complementary Medicine Evaluation offers a unique opportunity to analyse cardiovascular patients' satisfaction with CAM and conventional medical (COM) therapies. The treatment choices of doctors certified in conventional as well as complementary therapies also could be studied. A national observational evaluation on treatment satisfaction of patients consulting COM or CAM doctors. Out of this evaluation project, data related to patients with cardiovascular diseases were specifically analysed for patient satisfaction with treatment and outcome when treated by COM or CAM doctors. Of 199 included doctors (78 COM, 121 CAM) treating cardiovascular patients, COM doctors treated twice as many cardiovascular patients per doctor than CAM doctors. CAM doctors treated less than 1/3 of their cardiovascular patients solely by CAM, while they treated 42% exclusively by COM therapies. Patients seeing a CAM doctor had a significantly longer consultation and were more likely to be highly satisfied with overall treatment outcome and patient-practitioner communication. Moreover, pat...Continue Reading

References

Sep 23, 1988·JAMA : the Journal of the American Medical Association·A Donabedian
Nov 20, 1998·JAMA : the Journal of the American Medical Association·D M EisenbergR C Kessler
Nov 20, 1998·JAMA : the Journal of the American Medical Association·W B Jonas
Nov 20, 1998·Archives of Family Medicine·J JacobsD Crothers
Sep 4, 1999·The Medical Journal of Australia·C M MartinM Nisa
Oct 12, 1999·JAMA : the Journal of the American Medical Association·B G Druss, R A Rosenheck
Mar 17, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J A AstinW L Haskell
May 17, 2000·Complementary Therapies in Medicine·E Ernst, A White
Jan 16, 2002·JAMA : the Journal of the American Medical Association·David W KaufmanAllen A Mitchell
Feb 21, 2002·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·Amy L Ai, Steven F Bolling
Jul 4, 2002·BMC Complementary and Alternative Medicine·Jeff Blackmer, Ludmilla Jefromova
Oct 3, 2002·American Journal of Public Health·Chi-Keong OngSarah Stewart-Brown
Mar 18, 2003·Journal of Women's Health·Peter Franks, Klea D Bertakis
May 27, 2003·American Heart Journal·Malissa J WoodJafna L Cox
Jul 24, 2003·International Journal of Clinical Pharmacology and Therapeutics·N ShafiqP Pandhi
Mar 16, 2004·Annual Review of Public Health·Debra L Roter, Judith A Hall
Jun 11, 2004·Advance Data·Patricia M BarnesRichard L Nahin
Jul 21, 2004·BMC Complementary and Alternative Medicine·Karen J ShermanDavid M Eisenberg
Apr 2, 2005·Breast Cancer Research and Treatment·Eileen RakovitchMark Clemons
Apr 5, 2005·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Sunghye KimCarlos A Camargo
Aug 16, 2005·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Deanna J McKayRobert N Grimshaw
Aug 24, 2005·British Journal of Haematology·Nadine A RamsayJignesh P Patel

❮ Previous
Next ❯

Citations

Feb 14, 2009·Disease-a-month : DM·William H FrishmanChristine Carosella
Jul 19, 2013·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ana Paula Simões-WüstMarcel Dettling
May 17, 2011·Explore : the Journal of Science and Healing·Gunver Sophia KienleHelmut Kiene
Aug 7, 2010·Complementary Therapies in Medicine·Lai Yin WongKeng He Kong
Dec 23, 2011·Forschende Komplementärmedizin = Research in Complementary Medicine·Hans-Peter Studer, André Busato
Jan 1, 2012·Forschende Komplementärmedizin = Research in Complementary Medicine·Nina NissenHelle Johannessen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.